Free Trial

Adagio Medical (ADGM) Competitors

$1.65 -0.19 (-10.33%)
(As of 12/20/2024 05:15 PM ET)

ADGM vs. TELA, GUTS, MGRM, TMDIF, LNSR, WOK, NSPR, APYX, HSAQ, and DHAI

Should you be buying Adagio Medical stock or one of its competitors? The main competitors of Adagio Medical include TELA Bio (TELA), Fractyl Health (GUTS), Monogram Orthopaedics (MGRM), Titan Medical (TMDIF), LENSAR (LNSR), WORK Medical Technology Group LTD Ordinary Shares (WOK), InspireMD (NSPR), Apyx Medical (APYX), Health Sciences Acquisitions Co. 2 (HSAQ), and DIH Holding US (DHAI). These companies are all part of the "surgical & medical instruments" industry.

Adagio Medical vs.

TELA Bio (NASDAQ:TELA) and Adagio Medical (NASDAQ:ADGM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

Adagio Medical has lower revenue, but higher earnings than TELA Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TELA Bio$68.65M1.64-$46.66M-$1.69-1.69
Adagio Medical$266K90.16-$2.13MN/AN/A

94.3% of TELA Bio shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 6.0% of TELA Bio shares are held by company insiders. Comparatively, 53.5% of Adagio Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

TELA Bio currently has a consensus target price of $9.25, suggesting a potential upside of 224.56%. Given TELA Bio's stronger consensus rating and higher possible upside, research analysts clearly believe TELA Bio is more favorable than Adagio Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TELA Bio
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Adagio Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Adagio Medical has a net margin of 0.00% compared to TELA Bio's net margin of -60.49%. Adagio Medical's return on equity of 160.59% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
TELA Bio-60.49% -556.18% -63.13%
Adagio Medical N/A 160.59%40.99%

In the previous week, Adagio Medical had 3 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Adagio Medical and 0 mentions for TELA Bio. Adagio Medical's average media sentiment score of 0.22 beat TELA Bio's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the news media.

Company Overall Sentiment
TELA Bio Neutral
Adagio Medical Neutral

TELA Bio received 59 more outperform votes than Adagio Medical when rated by MarketBeat users.

CompanyUnderperformOutperform
TELA BioOutperform Votes
59
74.68%
Underperform Votes
20
25.32%
Adagio MedicalN/AN/A

TELA Bio has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Adagio Medical has a beta of -0.09, indicating that its stock price is 109% less volatile than the S&P 500.

Summary

Adagio Medical beats TELA Bio on 8 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADGM vs. The Competition

MetricAdagio MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$23.98M$4.34B$5.14B$9.08B
Dividend YieldN/A44.57%5.09%4.23%
P/E RatioN/A25.0190.0517.18
Price / Sales90.1645.901,116.25117.05
Price / CashN/A43.4443.1037.85
Price / Book-0.477.094.784.78
Net Income-$2.13M$13.64M$120.31M$225.60M
7 Day Performance-18.32%-2.93%-1.92%-1.23%
1 Month Performance-33.20%-1.42%13.65%0.46%
1 Year PerformanceN/A39.20%28.34%15.24%

Adagio Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADGM
Adagio Medical
N/A$1.65
-10.3%
N/AN/A$23.98M$266,000.000.0085News Coverage
Gap Down
High Trading Volume
TELA
TELA Bio
2.9878 of 5 stars
$2.83
+2.2%
$9.25
+226.9%
-53.6%$111.47M$58.45M-1.64120
GUTS
Fractyl Health
0.8734 of 5 stars
$2.12
+3.9%
$22.00
+937.7%
N/A$101.97M$120,000.00-0.17102
MGRM
Monogram Orthopaedics
3.2283 of 5 stars
$2.76
+3.8%
$4.00
+44.9%
-23.1%$94.70M$364,999.00-5.6628Gap Down
TMDIF
Titan Medical
N/A$0.82
-6.8%
N/A+563.3%$93.23M$17.63M11.004News Coverage
LNSR
LENSAR
0.5735 of 5 stars
$7.53
-0.3%
$8.00
+6.2%
+174.0%$87.46M$48.87M-5.17110News Coverage
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/A$5.48
+0.4%
N/AN/A$79.46MN/A0.00226Gap Up
High Trading Volume
NSPR
InspireMD
2.1916 of 5 stars
$3.00
+1.7%
$4.75
+58.3%
+45.6%$78.25M$6.82M-3.9350Analyst Forecast
Gap Up
APYX
Apyx Medical
1.6476 of 5 stars
$1.77
+5.4%
N/A-37.5%$66.63M$48.54M-2.23270
HSAQ
Health Sciences Acquisitions Co. 2
N/A$5.26
-1.5%
N/A-48.0%$58.98MN/A0.004Gap Down
DHAI
DIH Holding US
N/A$1.39
-0.7%
N/AN/A$56.37M$64.47M0.00N/A

Related Companies and Tools


This page (NASDAQ:ADGM) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners